Eur J Cancer Care (Engl). 2017 May 30. doi: 10.1111/ecc.12721. [Epub ahead of print]
Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.
© 2017 John Wiley & Sons Ltd.
anaplastic lymphoma kinase gene; epidermal growth factor receptor gene; non-small cell lung cancer; oncogenic drivers; prevalence; testing frequency